AMD3100 plus G-CSF rapidly mobilizes hematopoietic progenitor cells in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM), including those traditionally considered “poor mobilizers”

Stiff, P.Mcallef, I.McCarthy, P.Magalhaes-Silverman, M.Fromenberg, N.Weisdorf, D.Tricot, G.Territo, M.Abodnour, R.Badel, K.Calandra, G.2020-12-232020-12-232005-02-01Stiff, P., Micallef, I., McCarthy, P., Magalhaes-Silverman, M., Fromenberg, N., Weisdorf, D., ... & Calandra, G. (2005). AMD3100 plus G-CSF rapidly mobilizes hematopoietic progenitor cells in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM), including those traditionally considered “poor mobilizers”. Biology of Blood and Marrow Transplantation, 11(2), 92.https://hdl.handle.net/1805/24722en-USAttribution-NonCommercial-NoDerivatives 4.0 Internationalselective antagonistG-CSFAMD3100AMD3100 plus G-CSF rapidly mobilizes hematopoietic progenitor cells in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM), including those traditionally considered “poor mobilizers”Article